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Objective: Overweight and  low physical activity (PA) increase the risk of prostatic enlargement (PE) and 
erectile dysfunction (ED). Less clear is the role of these factors at young age on the lifelong risk. 
Material and Methods: During June 2018 the Italian Society of Urologists organized the month of Male 
Urologic Prevention ”#Controllati”.  Men aged 18 years or more were invited to attend urologic centers for a 
visit and  counselling about urologic/ andrologic conditions. Each participating man  underwent a physical 
examination  and was asked  about   urologic symptoms, sexual activity and possible related problems.  
Results:  We analyzed data from 2786 men, aged 55.1 years (SD 10.9, range 19-97). A total of 710 (25.5%) 
subjects had a diagnosis of  PE and 632 (22.7%) of DE. Overweight/obese men were at increased risk of  PE  
and  ED the corresponding odds ratio,0R, in comparison with normal or underweight men, being respectively  
1.18 (95%Confidence Interval, CI, 1.00-1.44) and OR 1.69 (95%CI 1.39-2.05). In comparison with men reporting 
at age 25  a BMI <25.0 the OR of PE was among men with a BMI at 25 years of age ≥ 25 was.0 1.22 (95%CI 
1.01-1.51); the corresponding value for ED was 1.17 (0.92-1.48).Considering  total PA at diagnosis,  the OR of 
PE was, in comparison with no or low PA, 0,69(95%CI 0,55-0,86) among men reporting moderate  PA and 0,75 
(95%CI 0,58-0,98) among those reporting intense PA. When we considered PA at 25 years of age, the OR of 
subsequent diagnosis of PE were, in comparison with men reporting no/low PA at 25 years of age,  0,81(95%CI 
0,63-1,04) for men reporting moderate PA and 0,70(95%CI 0,52-0.99) for those reporting intense PA. 
Conclusion: These findings underline the role of encouraging healthy lifestyle habits among  young men in 
order to reduce the subsequent risk of PE  and ED. 
 




Benign prostatic enlargement (PE) and erectile dysfunction (ED) are the two most common urologic diseases 
in men, the estimated  prevalence of PE being  about 10% in the fourth decades increasing till 50% thereafter  
and of ED being of 12% (1,2). 
Among the risk factors for these two conditions lifestyles play a major role.  
It is well recognized, for example, that overweight, low physical activity (PA), hypertension,  
hypercholesterolemia, hypertriglyceridemia increase the risk of these conditions at advanced ages. (3-6). 
Less clear is the role of these factors at young age on the lifelong risk (7). 
Since 2016 the Italian Urologic Society (SIU, Società Italiana di Urologia) coordinates a huge preventive 
initiative: the month  of Male Urologic Prevention ”#Controllati”. (8,9) 
 In the framework of this preventive campaign data have been collected  on determinants of the risk of PE  
and ED. 
In this paper we present the results of the 2018  initiative with a special focus on risk factors for PH and ED at 




During June 2018, men aged 18 years or more were invited to attend participating urologic centers for a free 
of charge visit and counselling about urologic or andrologic conditions.  
A pamphlet inviting men for check-up  was distributed in chemists and general practitioners’ waiting rooms. 
An advertising campaign was also set in the press.  
At the moment of the visit,  general data were recorded using a simple questionnaire.  
The first section of the questionnaire, including data on age, life habits height and weight,  was completed by 
the patient. 
The section on PA included questions on self reported intensity (‘none’, ‘low’, ‘moderate’, ‘ intense’) of 
activity at work and in leisure time separately.  History of hypertension, diabetes, cardiopathy, 
hypertriglyceridemia and hypercholesterolemia were checked by the urologist. Information have been also 
collected on body mass index (BMI) and total PA at age 25 years among men aged 30 years or more. 
Each participating man  underwent a physical examination (including digital rectal examination, DRE) 
and was asked by the urologist about urologic symptoms, sexual activity and possible related problems. 
Diagnosis of PE was made by the urologist after DRE. 
Erectile function was assessed by asking men about their sexual performance: ED was diagnosed 
according to the definition of the NIH Consensus Development Panel (10), when a man was consistently 
unable to attain or maintain a penile erection sufficient for satisfactory sexual performance.  
The 2002 ICS definitions were used for frequency, nocturia, urgency, dysuria (intermittency, slow 
stream, straining, terminal dribble, postmicturition dribble) incomplete emptying (11). 
Smoker was defined a man who had smoked more than one cigarette/day for at least one year;  ex-
smoker a  man who had smoked more than one cigarette/day for at least one year, but had stopped 
more than one year before the interview, and  non-smoker if he had never smoked more than one 
cigarette/day.  
Total PA was evaluated combining occupational and leisure time PA.  
Frequencies (percent,%) were computed as appropriate. Odds ratios (OR), and the corresponding 95% 
confidence intervals (CI), adjusted for age were derived using unconditional multiple logistic regression, 
fitted by the method of maximum likelihood, in which the dependent variable was the presence (case) 
or absence (control) of the condition and the independent ones were the exposures considered in the 
analysis. We included in the model age considered as categorical variables (12). 
 
 Results   
During the 2018 campaign a total of 3092 men entered the study. After  exclusion of  men who 
underwent previous surgery for partial and complete prostatectomy and those who did not answer at 
least one of two questions about PA,  we analyzed data from 2786 men, aged 55.1 years (SD 10.9, range 
19-97). The reason for visit was urinary symptoms in 504 (18.1%), sexual problems in 270 (9.7%), renal 
disease in 68 (2.4%) and prostatic problems in 429 (15.4%)(more than one reason was allowed). 
Prevention was the only reason for consultation in 1776 subjects (63.8%). 
A total of 710 (25.5%) subjects  had a diagnosis of  PE and 632 (22.7%) of DE. 
Table 1 shows the distribution, and the corresponding OR, of study subjects according to the diagnosis 
of PE, ED and age , smoking habits and BMI.  
The risk of PE and ED  increased with age: in comparison with men aged <=40 years or less, the risk of  
PE was  respectively 2.57. 7.22 17.97 and 39.1 in the age classes  41-50, 51-60, 61-70 and >=71. The 
corresponding values for ED were 1.15, 1.63, 3.06 and 4.87. 
Smoking increased the risk of ED: in comparison with never smokers, ex smokers had an increased risk 
of ED of 1,38 (95%CI 1,11-1,69), and current smokers of 1,92(95%CI 1,49-2,48). 
 
Overweight/obese men were at increased risk of  PE  and  ED the corresponding 0R, in comparison with 
normal or underweight men, being respectively  1.18 (95%CI 1.00-1.44) and OR 1.69 (95%CI 1.39-2.05). 
We have also considered (among men aged 30 years or more) the role of overweight/obesity at 25 years 
of age  on the subsequent risk of PE and ED. 
In comparison with men reporting at age 25  a BMI <25.0, the OR of PE was, among men with a BMI at 
25 years of age ≥ 25, 0 1.22 (95%CI 1.01-1.51); the corresponding value for ED was 1.17 (95%CI 0.92-
1.48). 
Table 2 considers the relation between PE and DE and  urinary symptoms, hypertension, diabetes, 
cardiopathy, hypertriglyceridemia and hypercholesterolemia. 
A history of hypertension, diabetes, cardiopathy,  high cholesterol levels    were significantly associated 
to an increased PE risk in the total series. Likewise, hypertension, diabetes, cardiopathy,  high 
triglyceride and  cholesterol levels were significantly associated to an increased risk of  ED.  
PA was significantly associated with a decreased risk of PE: considering the total PA at diagnosis,  the OR 
of PE was, in comparison with men reporting no or low PA, 0,69 (95% CI 0,55-0,86) among men 
reporting moderate  PA and  0,75(0,58-0,98)among those reporting intense PA. 
The OR of subsequent diagnosis of PE were, in comparison with men reporting no/low PA at 25 years of 
age  0,81 (95%CI 0,63-1,04) for men reporting moderate PA and 0,70 (95%CI0,52-0.99) for those 





The general results of this analysis  show that  low PA, high BMI and a history of hypertension, diabetes,  
hypercholesterolemia, cardiopathy increase the risk of PE.  High BMI and low PA at 25 year of age 
increase the risk of PE  at older ages. Similar results emerged also for the risk profile of ED. 
 
Limitations 
As already discussed in the papers presenting the results of 2016 and 2017 initiative (8,9), the major 
flaw of this study is that the study population were men voluntarily presenting to the participating 
centers.  The participating centers were not randomly identified among all Italian urologic centers, so 
they cannot be considered representative of all Italian centers. However, they were well distributed 
over the main areas of the country. In any case, any inference from the present analysis must be made 
in strictly comparative terms and strictly referred to men attending  urologic services. 
The diagnosis of PE was based on DRE that tends to underestimate the prostatic volume (2). Any 
misclassification of men with or without BPE or should lower the observed associations. 
With regard to the diagnosis of DE it was reported by the men and checked for standard criteria by the 
physician. 
The results of this study confirm data from different populations that have reported that high BMI, low 
PA and a history of hypertension, diabetes,  hypercholesterolemia,  increase the risk of PE at all ages. 
(13,14) 
All these findings underline that benign PE shares similar risk factors with metabolic syndrome and  
cardiovascular diseases.   
The etiological mechanisms that links these  risk factors and the prostatic growth is not completely 
understood. However, it has been shown  that lipids (oxidized low-density lipoprotein) increase in vitro 
the secretion of growth and pro-inflammatory factors  by human stromal BPE cells in culture (15). Along 
this line, in a clinical perspective, the addition of statins  to standard  therapy for benign PE lowered  
prostate volume (16).  Further, alteration of sex steroid hormone metabolism caused by both obesity 
and diabetes could lead to ‘pro-inflammatory’ conditions, causing release of chemokines potentially 
associated with prostate enlargement. (17) 
Regular PA  it has been consistently reported to decrease the risk of PE. A  meta-analysis  has shown that  
moderate-to-vigorous physical activity was associated with up to a 25% decreased risk of benign PE, 
with the magnitude of the protective effect increasing with the higher levels of activity (18). 
An interesting  findings from the present study is the observation that the OR of PE and ED associated 
with none/low PA and high BMI at 25 years were higher than unity.   
Few data have been published on the role of PA at younger ages on the lifetime risk of PE. A previous 
Italian case control study have reported that moderate/intense recreational physical activity (>2 hours 
week) at age 30-39 decrease  the risk of benign PE of about 30%.The Authors concluded that avoidance 
of sedentary lifestyle through a moderate recreational PA at any age may help preventing a sizeable 
number (e.g., approximately 20%) of benign PE cases (7). 
With regard to erectile dysfunction, the risk profile of ED was largely similar with that observed for PE. In 
particular,  the present analysis confirms that smoking, overweight, low PA and  a history of diabetes,  
hypertension, cardiopathy,  hypercholesterolemia, hypertriglyceridemia, all  increased the risk of ED.   
All these findings underline the role of encouraging healthy lifestyle habits among young  men  in order 
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Table 1.Odds ratios (and corresponding 95% confidence intervals) of BPE and erectile dysfunction according to selected factors. 
*Sometimes, the sums do not add up the total due to missing values 
°reference category OR: odds ratio; CI: confidence interval.  Nd. Not determined 
 Benign prostatic enlargement 
 
 
Age adj OR (95%CI) 
Erectile dysfunction  
 











(years)     
 
    
 
≤40 
166 7.8 7 0.9 
1 
150 6.8 23 3.5 
1 
41-50 
782 36.8 87 11.5 
2.57  (1.17-5.66) 
736 33.2 133 20.0 
1.15 (0.71-1.85) 
51-60 
718 33.8 225 29.6 
7.22  (3.34-15.63) 
752 33.9 191 28.7 
1.63 (1.02-2.60) 
61-70 
339 16.0 269 35.4 
17.97  (8.29-38.96) 
413 18.6 195 29.3 
3.06 (1.91-4.90) 
≥ 71 
118 5.6 171 22.5 
35.10  (15.83-77.86) 




         
 
Never 
1131 53.3 342 45.1 
1 
1198 54.1 275 41.3 
1 
Ex 
smokers 624 29.4 303 39.9 
1,2(0.98-1.47) 
668 30.1 259 38.9 
1.38 (1.12-1.69) 
Current 
smokers 343 16.2 103 13.6 
1,1(0.84-1.47) 




127 8.5 34 7.5 
0.94(0.58-1.53) 
130 8.5 31 7.6 1.49  (0.96-2.29) 
≥ 10 
cig/day 
192 12.9 67 14.8 
1.27 (0.90-1.78) 
174 11.3 85 21.0 2.25  (1.66-3.06) 
BMI 
(kg/m2)  
         
 
<25.0  891 43.2 253 35.8 1 949 44.1 195 30.8 1 
≥25.0 
1172 56.8 453 64.2 
118. (1.00-1.44) 
1189 55.2 436 69.0 
1.69 (1.39-2.05) 
BMI at 25 
years of 
age** 
     
    
 
<25.0  1293 62.3 443 62.4 1 1335 62.0 401 63.4 1 
≥ 25.0 
384 18.5 123 17.3 
1.22 (1.01-1.51) 
 381 17.7 126 19.9 
1.17 (0.92-1.48) 
Table 2.Odds ratios (and corresponding 95% confidence intervals) of BPE and erectile dysfunction according to medical history, 
 Benign prostatic enlargement  
 
adjOR (95%CI) 












symptoms°*     
 
    
 
No 
987 46.5 101 13.3 
 
1° 924 41.7 164 24.6 
1 
Yes 
1136 53.5 658 86.7 
5,14 




         
 
No  1698 80.0 518 68.2 1 - - - - - 
Yes 425 20.0 241 31.8 1,27(1,03-1,57) - - - - - 
Benign prostatic 
enlargement 
     
    
 
No - - - - - 1698 76.6 425 63.8 1 
Yes - - - - - 518 23.4 241 36.2 1.27 (1,03-1.57) 
Hypertension           
No 1492 70.3 369 48.6 1 1524 68.8 337 50.6 1 
Yes 407 19.2 275 36.2 1,6(1,30-2,619 457 20.6 225 33.8 1.60 (1.29-1.99) 
Missing 224 10.6 115 15.2  235 10.6 104 15.6 -- 
Diabetes           
No  1884 88.7 599 78.9 1 1964 88.6 519 77.9 1 
Yes 78 3.7 80 10.5 1,57(1,08-1,85) 82 3.7 76 11.4 2,43 (1.70-3.47) 
Missing 161 7.6 80 10.5  170 7.7 71 10.7 - 
Cardiopathy            
No 1857 87.5 577 76.0 1 1925 86.9 509 76.4 1 
Yes 
76 3.6 74 9.7 
1,30 
(1,02-1,67) 80 3.6 70 10.5 
2.12 (1.47-3.06) 
Missing 190 8.9 108 14.2  211 9.5 87 13.1 - 
Hypertriglyceride
mia  
    
 
    
 
No 
1753 82.6 586 77.2 
1 
1830 82.6 509 76.4 1 
Yes 
130 6.1 62 8.2 
1,31(0,92-1,85) 
130 5.9 62 9.3 1.59 (1.13-2.22) 
Missing 
240 11.3 111 14.6 
 
256 11.6 95 14.3 - 
Hypercholesterol           
emia 
No 
1548 72.9 492 64.8 
1 
1613 72.8 427 64.1 1 
Yes 
301 14.2 143 18.8 
1,30(1,02-1,67) 
315 14.2 129 19.4 1.42 (1.11-1.81) 
Missing 
274 12.9 124 16.3  288 13.0 110 16.5 - 
*Sometimes, the sums do not add up the total due to missing values 
**one or more of the followings: nocturia, urgency, dysuria (intermittency, slow stream, straining, terminal dribble, postmicturition 
dribble) incomplete emptying. 
°reference category  




















Table 3.Odds ratios (and corresponding 95% confidence intervals) of premature ejaculation and erectile dysfunction according to physical 
activity. 
 Benign prostatic enlargement  
 
 adjOR (95%CI) 













    
 
    
 
None/Low  
1002 48.3 354 49.9 
1 
1035 48.1 321 50.8 1 
Moderate 
631 30.4 198 27.9 
0,89 
(0,7-1,1) 
657 30.5 172 27.2 
0,86 (069-1.08) 
Intense 
283 13.6 80 11.3 
0,97(0,72-1,31) 
286 13.3 77 12.2 
0.98 (0.73-1.30) 
Missing 
160 7.7 78 11.0 
 




    
 
    
 
Low  
767 36.9 317 44.6 
1 
785 36.4 299 47.3 
1 
Moderate 
893 43.0 272 38.3 
0,67(0,55-0,83) 
926 43.0 239 37.8 
0.66 (0.54-0.80) 
Intense 319 15.4 84 11.8 0,64 (0,51-0,91) 342 15.9 61 9.7 0.48 (0.36-0.66) 
Missing 97 4.7 37 5.2  101 4.7 33 5.2 - 
Total PA           
Low 537 25.9 228 32.1 1 544 25.3 221 35.0 1 
Moderate 960 46.2 308 43.4 0,69(0,55-0,86) 995 46.2 273 43.2 0.65 (0.53-0.80) 
Intense 515 24.8 144 20.3 0,75(0,58-0,98) 545 25.3 114 18.0 0.56 (0.43-0.72) 
Missing 64 3.1 30 4.2  70 3.2 24 3.8 - 
PA at 25 
years of 
age     
 
    
 
Low 401 19.3 160 22.5 1 415 19.3 146 23.1 1 
Moderate 820 39.5 273 38.5 0,81(0,63-1,04) 858 39.8 235 37.2 0.78 (0.61-0.99) 
Intense 773 37.2 244 34.4 0,70(0,52-0.99) 785 36.4 232 36.7 0.74 (0.58-1.10) 
Missing 82 3.9 33 4.6  96 4.5 19 3.0 - 
*Sometimes, the sums do not add up the total due to missing values 
°reference category adjOR:  adjusted odds ratio; CI: confidence interval.  
 
*Participating centers: 
A.O.U. Città della Salute e della Scienza - Ospedale Molinette, Torino (Gontero Paolo)  
Arcispedale Sant'Anna Ferrara (Ippolito Carmelo); ASL Reggio Calabria (De Martin Michele):P.O. 
Umberto I, Nocera Inferiore(Sanseverino Roberto):ASL Presidio Ospedaliero Carmagnola, Chieri (Marino 
Gaetano): ASST Franciacorta - Ospedale M. Mellini  (Chiari Tralce Luigi); Ospedale Mater Salutis Legnago 
(Curti Pierpaolo); Aurelia Hospital, Roma (Cusumano Roberto); Azienda Ospedaliera Universitaria di 
Sassari (Madonia  Massimo); Azienda Ospedaliera "Umberto I" Siracusa (Lentini Bartolomeo); Azienda 
Ospedaliera  Universitaria, Parma (Maestroni Umberto Vittorio); Azienda Ospedaliera, Padova (Zattoni 
Filiberto); Azienda Ospedaliera Gaetano Rummo Benevento (Salzano Luigi); Azienda Ospedaliera 
Ospedali Riuniti Papardo Piemonte, Messina (Mastroeni Francesco); Azienda Ospedaliera Policlinico di 
Bari (Ditonno Pasquale); Azienda Ospedaliera Policlinico di Bari (Battaglia Michele); Azienda Ospedaliera 
Pugliese Ciaccio Catanzaro (Pirritano Domenico); Azienda Ospedaliera S. Antonio e Biagio, Alessandria 
(Serao Armando); Azienda Ospedaliera S. Bortolo, Vicenza  (Ferrarese Paolo); Azienda Ospedaliera S. 
Giuseppe Moscati, Avellino (Cicalese Virgilio); Azienda Ospedaliera Sant’Anna e San Sebastiano di 
Caserta (Caggiano Sergio); Azienda Ospedaliera Santa Maria Terni (Elisabetta Costantini); Azienda 
Ospedaliera Universitaria - "L. Vanvitelli" Napoli (De Sio Marco); Azienda Ospedaliera Universitaria 
Integrata Verona  (Artibani Walter); Azienda Ospedaliera Universitaria Mater Domini di Catanzaro 
(Damiano Rocco); Azienda Ospedaliera Universitaria Policlinico G. Martino Messina (Ficarra Vincenzo); 
Azienda Ospedaliero - Universitaria "Policlinico - Vittorio Emanuele" Catania (Falsaperla Mari); Azienda 
Ospedaliero - Universitaria Careggi, Firenze (Carini Marco); Azienda Ospedaliero - Universitaria S. Luigi 
Gonzaga Orbassano (Porpiglia Francesco); Azienda Ospedaliero Universitaria Maggiore della Carità, 
Novara (Volpe Alessandro); Azienda Ospedaliero Universitaria Pisana - Stabilimento di Cisanello (Selli 
Cesare); Azienda Ospedaliero Universitaria Sant' Andrea, Roma (Tubaro Andrea); Ospedale Civile di  
Voghera (Mensi Mario); Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, Milano (Dormia Guido); 
Campus Università degli Studi "Gabriele d'Annunzio" Chieti (Raffaele Tenaglia); Casa di Cura Ambrosiana 
Cesano Boscone (Catanzaro Francesco); Casa di Cura Gibiino Catania (Ranno Christian); Casa di Cura 
Giovanni XXIII, Monastier di Treviso (Morana Carmelo); Casa di Cura Guarnieri, Roma (Di Marco 
Massimiliano); Casa di Cura Luigi Cobellis Vallo della Lucania (Cavaliere Aniello); Casa di Cura Malatesta 
Novello Cesena (Cuzzocrea Diego);Casa di Cura Musumeci Gecas Gravina di Catania (Leonardi Rosario); 
Casa di Cura Nuova Clinica Santa Rita Benevento (Coscione Mario); Casa di Cura Nuova Villa Claudia,  
Roma  (Giulianelli Roberto); Casa di Cura Regina Pacis,  San Cataldo (Cammarata Carla); Casa di Cura 
Romolo Hospital Rocca di Neto (Cappa Manlio); Casa di Cur S. Rita, Atripalda De Simone Elia Virginio; 
Casa di Cura San Camillo Messina (Bruschetta Sebastiano); Casa di Cura Santa Lucia San Giuseppe 
Vesuviano (Casoli Eugenio); Casa di Cura Sileno ed Anna Rizzola, San Donà di Piave (Loiero Gaetano); 
Casa di Cura Trusso, Ottaviano (De Stefano Giacomo); Casa Di Cura Villa Betania, Roma (Buscarini 
Maurizio); Casa di Cura Villa dei Fiori, Mugnano di Napoli (Jungano Renato); Casa di Cura Villa Esther, 
Avellino (Di Martino Mario); Casa di Cura Villa Fiorita, Prato (Dami Andrea Cesare); Casa di Cura Villa 
Igea , Ancona (Cafarelli Angelo); Casa di Cura Villa Maria, Mirabella Eclano (Morelli Emilio); Casa di Cura 
Villa Stabia Castellammare di Stabia (Scognamiglio Giuseppe); Centro Medico Politerapica, Seriate (Paolo 
Belvisi); Clinica Athena Villa dei Pini,  Piedimonte Matese (Dalena Giuseppe); Clinica Padre Pio, 
Mondragone (Sepe Giuseppe Salvatore); Clinica Pierangeli, Pescara (Pompa Paolo); Clinica Villa Pia, 
Roma (Campagna Adriano); Casa di Cura Pederzoli, Peschiera del Garda (Grosso Gaetano) ; Ospedale 
Generale Regionale F. Miulli,  Acquaviva delle Fonti (Ludovico Giuseppe Mario); Ospedale Galliera, 
Genova (Introini Carlo);  Fondazione Policlinico IRCCS , Milano  (Montanari Emanuele); Fondazione PTV 
Policlinico, Tor Vergata, Roma (Vespasiani Giuseppe); Grande Ospedale Metropolitano Bianchi 
Melacrino Morelli,  Reggio Calabria  (Cozzupoli Pietro); Hesperia Hospital, Modena (Ferrari Giovanni); 
Humanitas Gradenigo, Torino  (Muto Giovanni) ; Humanitas San Pio X, Milano (Nava Luciano); IRCCS 
Policlinico San Donato (Carmignani Luca); IRCCS AOU San Martino IST, Genova (Terrone Carlo); Istituti 
Clinici Zucchi, Monza  (Stefano Casellato); Istituto Clinico S.Anna, Brescia (Najati Alrabi); Istituto Europeo 
di Oncologia, Milano (De Cobelli Ottavio); Istituto Nazionale Tumori IRCCS "Fondazione Pascale" Napoli  
(Perdonà Sisto); Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo (Cisternino Antonio); 
Ospedale Buon Consiglio Fatebenefratelli, Napoli (Imperatore Vittorio); Ospedale Cardarelli, Napoli 
(Fedelini Paolo); Ospedale Carlo Urbani,  Jesi (Ferrara Vincenzo); Ospedale Civico di Cristina Benfratelli , 
Palermo (Gianfranco Savoca); Ospedale Civile di Guastalla (Frattini Antonio); Ospedale Civile P.O. 
Dell'Annunziata, Cosenza (Emilio De Giacomo); Ospedale Civile Ramazzini Carpi (Barusi Maurizio); 
Ospedale Civile S. Giacomo, Monopoli (Vito Domenico Ricapito); Ospedale Civile San Salvatore, L’Aquila  
(Di Clemente Luigi); Ospedale Cottolengo, Torino  (Scoffone Cesare Marco); Ospedale degli Infermi, 
Rimini (Montanari Francesco); Ospedale del Mare, Napoli (Zito Aniello Rosario) ; Ospedale della Murgia 
Fabio Perinei, Altamura (De Siati Mario); Ospedale di Bassano del Grappa (Celia Antonio); Ospedale di 
Belcolle, Viterbo (Rizzotto Antonio); Ospedale di Senigallia (Vincenzo Ferrara); Ospedale di Sondrio 
(Giumelli Pierluigi); Ospedale di Villafranca di Verona (Pecoraro Giuseppe); Ospedale Cristo Re, Roma 
(Lorenzo Defidio); Ospedale Don Tonino Bello Molfetta (Altomare Mauro); Ospedale Garibaldi  Nesima, 
Catania (La Rosa Pasquale Gianfranco); Ospedale ICOT, Latina  (Carbone Antonio); Ospedale L. Bonomo, 
Andria  (Corvasce Antonio); Ospedale Madonna delle Grazie, Matera  (Disabato Giuseppe); Ospedale 
Maggiore, Bologna (Emili Emilio); Ospedale Maria SS. Addolorata, Erboli  (Tufano Antonio);  Ospedale 
Niguarda Ca' Granda, Milano (Bocciardi Aldo); Ospedale Privato Accreditato Villa Regina, Bologna 
(Cuzzocrea Diego Ettore); Ospedale Villa Serena, Forlì (Zambelli Massimo); Ospedale S. Giacomo di Novi 
Ligure (Montefiore Franco); Ospedale S. Giovanni in Persiceto (Emilo Emili); Ospedale S. Maria della 
Misericordia, S. Andrea delle Fratte Perugia  (Ettore Mearini); Ospedale S. Maria delle Croci, Ravenna 
(Voce Salvatore); Ospedale S. Raffaele Turro, Milano (Gaboardi Franco); Ospedale Sacro Cuore di Gesù 
Fatebenefratelli, Benevento  (Ferravante Paolo); Ospedale Sacro Cuore Don Calabria, Negrar  (Cavalleri 
Stefano); Ospedale San Bartolomeo, Sarzana (Conti Enrico); Ospedale San Biagio DomodossolaRosa 
Antonio; Ospedale San Camillo Forlanini, Roma (Gaffi Marco); Ospedale San Donato, Arezzo (De Angelis 
Michele); Ospedale San Giacomo Apostolo, Castelfranco Veneto (Luca De Zorzi); Ospedale San Giovanni 
Battista, Foligno (Mearini Luigi); Ospedale San Giovanni di Dio, Agrigento (Ruoppolo Michele); Ospedale 
San Pio da Pietrelcina, Vasto (Schips Luigi); Ospedale San Raffaele, Milano (Montorsi Francesco); 
Ospedale San Salvatore. Pesaro (Beatrici Valerio); Ospedale San Tommaso dei Battuti, Portogruaro 
(Amenta Michele); Ospedale Sant'Ottone Frangipane, Ariano Irpino (Grasso Gerardo); Ospedale Santa 
Maria Misericordia, Udine (Valotto Claudio); Ospedale Santa Maria Regina degli Angeli, Adria 
(Meneghini Agostino); Ospedale Santissima Trinità, Cagliari (De Lisa Antonello); Ospedale Spoke, Locri 
(Capocasale Francesco); Ospedale SS. Capitanio e Gerosa, Lovere (Ranieri Antonio); Ospedale Vincenzo 
Monaldi, Napoli  (Uricchio Francesco); Ospedali Riuniti di Ancona (Galosi Andrea Benedetto); Ospedali 
Riuniti di Foggia (Carrieri Giuseppe), Presidio Ospedaliero Cerignola (Annunziata Gennaro); P.O. S. Marta 
e S. Venera di Acireale (Ingrassia Antonino); P.O.Umberto I, Enna  (D'Anca Michele); Policlinico Agostino 
Gemelli, Roma (Bassi Pierfrancesco); Policlinico di Abano Terme (Porreca Angelo); Ospedale Civile di 
Baggiovara (Bianchi Giampaolo); Policlinico Federico II, Napoli (Mirone Vincenzo); Policlinico S. Orsola – 
Malpighi,  Bologna (Brunocilla Eugenio); Policlinico SS. Annunziata, Chieti (Schips Luigi); Polo Pontino- 
Ospedale ICOT, Latina (Carbone Antonio); Presidio Ospedaliero " Vittorio Emanuele ", Gela (Condorelli 
Sebastiano); Policlinico “Vittorio Emanuele”,  Catania (Morgia Giuseppe); Presidio Ospedale S.S. Pietro e 
Paolo, Borgosesia (Cipollone Giovanni), Presidio Ospedaliero Carlo Poma, Mantova (Dall'Oglio Bruno) 
Presidio Ospedaliero CTO – Unità Spinale Struttura di Neuro Urologia, Torino (Carone Roberto); Presidio 
Ospedaliero di Brescia (Simeone Claudio); Presidio Ospedaliero di Busto Arsizio (Buizza Carlo); Presidio 
Ospedaliero di Pescara (Renzetti Roberto); Presidio Ospedaliero Mazzini,  Teramo  (Vicentini Carlo); 
Presidio Ospedaliero Occidentale, Castellaneta (Di Lena Sebastiano); Presidio Ospedaliero Perrino, 
Brindisi (Brigante Salvatore); Presidio Ospedaliero S. Andrea, Vercelli (Cipollone Giovanni) ; Ospedale S. 
Maria del Prato, Feltre (Xausa Daniele); Villa Pini D'Abruzzo, Chieti (Marascia Gabriele) 
  
 
